Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial.

Please login or register to bookmark this article
Bookmark this %label%

To quantify the prevalence of co-morbidities in patients with early RA and determine their prognostic value for effectiveness outcomes in a randomized trial.We included patients from the 2-year pragmatic randomized CareRA trial, who had early RA (diagnosis 

View the full article @ Rheumatology (Oxford, England)
Get PDF with LibKey